newsfilter
← Latest News
Business Wire·

Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

  • Amylyx Pharmaceuticals will report fourth quarter and full year 2025 financial results on Tuesday, March 3, 2026.
  • Senior management will host a conference call & audio webcast at 8:00 a.m. ET to discuss financial results & company updates.
  • Participants can dial +1 (888) 880-3330 (U.S. & Canada) or +1 (646) 357-8766 (international) at least 10 minutes before the start time.
  • A live audio webcast will be available under "Events and Presentations" in the Investor section of the Company's website.
  • The webcast will be archived for replay for 90 days following the event.
  • Amylyx is currently focused on four investigational therapies across endocrine conditions & neurodegenerative diseases.